481 related articles for article (PubMed ID: 24409169)
1. Update on the Angiotensin converting enzyme 2-Angiotensin (1-7)-MAS receptor axis: fetal programing, sex differences, and intracellular pathways.
Chappell MC; Marshall AC; Alzayadneh EM; Shaltout HA; Diz DI
Front Endocrinol (Lausanne); 2014 Jan; 4():201. PubMed ID: 24409169
[TBL] [Abstract][Full Text] [Related]
2. Nonclassical renin-angiotensin system and renal function.
Chappell MC
Compr Physiol; 2012 Oct; 2(4):2733-52. PubMed ID: 23720263
[TBL] [Abstract][Full Text] [Related]
3. Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?
Chappell MC
Am J Physiol Heart Circ Physiol; 2016 Jan; 310(2):H137-52. PubMed ID: 26475588
[TBL] [Abstract][Full Text] [Related]
4. Physical Exercise and ACE2-Angiotensin-(1-7)-Mas Receptor Axis of the Renin Angiotensin System.
Nunes-Silva A; Rocha GC; Magalhaes DM; Vaz LN; Salviano de Faria MH; Simoes E Silva AC
Protein Pept Lett; 2017 Nov; 24(9):809-816. PubMed ID: 28758593
[TBL] [Abstract][Full Text] [Related]
5. ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension.
Mendoza-Torres E; Oyarzún A; Mondaca-Ruff D; Azocar A; Castro PF; Jalil JE; Chiong M; Lavandero S; Ocaranza MP
Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):217-37. PubMed ID: 26275770
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of angiotensin converting enzyme 2 and nuclear factor-κB by angiotensin II receptor subtypes in type 2 diabetic kidney.
Pandey A; Goru SK; Kadakol A; Malek V; Gaikwad AB
Biochimie; 2015 Nov; 118():71-81. PubMed ID: 26271886
[TBL] [Abstract][Full Text] [Related]
7. New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II.
Zhuo JL; Li XC
Peptides; 2011 Jul; 32(7):1551-65. PubMed ID: 21699940
[TBL] [Abstract][Full Text] [Related]
8. Fetal programming and the angiotensin-(1-7) axis: a review of the experimental and clinical data.
South AM; Shaltout HA; Washburn LK; Hendricks AS; Diz DI; Chappell MC
Clin Sci (Lond); 2019 Jan; 133(1):55-74. PubMed ID: 30622158
[TBL] [Abstract][Full Text] [Related]
9. ACE2-Ang-(1-7)-Mas Axis in Brain: A Potential Target for Prevention and Treatment of Ischemic Stroke.
Jiang T; Gao L; Lu J; Zhang YD
Curr Neuropharmacol; 2013 Mar; 11(2):209-17. PubMed ID: 23997755
[TBL] [Abstract][Full Text] [Related]
10. Role of the renin-angiotensin system in hepatic fibrosis and portal hypertension.
Shim KY; Eom YW; Kim MY; Kang SH; Baik SK
Korean J Intern Med; 2018 May; 33(3):453-461. PubMed ID: 29462546
[TBL] [Abstract][Full Text] [Related]
11. The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.
Li XC; Zhang J; Zhuo JL
Pharmacol Res; 2017 Nov; 125(Pt A):21-38. PubMed ID: 28619367
[TBL] [Abstract][Full Text] [Related]
12. Novel roles of nuclear angiotensin receptors and signaling mechanisms.
Gwathmey TM; Alzayadneh EM; Pendergrass KD; Chappell MC
Am J Physiol Regul Integr Comp Physiol; 2012 Mar; 302(5):R518-30. PubMed ID: 22170620
[TBL] [Abstract][Full Text] [Related]
13. ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis.
Simões E Silva AC; Teixeira MM
Pharmacol Res; 2016 May; 107():154-162. PubMed ID: 26995300
[TBL] [Abstract][Full Text] [Related]
14. Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis.
Iwai M; Horiuchi M
Hypertens Res; 2009 Jul; 32(7):533-6. PubMed ID: 19461648
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin type 2 receptor null mice express reduced levels of renal angiotensin II type 2 receptor/angiotensin (1-7)/Mas receptor and exhibit greater high-fat diet-induced kidney injury.
Ali Q; Dhande I; Samuel P; Hussain T
J Renin Angiotensin Aldosterone Syst; 2016 Jul; 17(3):. PubMed ID: 27496559
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis protects against lung fibrosis by inhibiting the MAPK/NF-κB pathway.
Meng Y; Yu CH; Li W; Li T; Luo W; Huang S; Wu PS; Cai SX; Li X
Am J Respir Cell Mol Biol; 2014 Apr; 50(4):723-36. PubMed ID: 24168260
[TBL] [Abstract][Full Text] [Related]
17. ACE and ACE2 in kidney disease.
Mizuiri S; Ohashi Y
World J Nephrol; 2015 Feb; 4(1):74-82. PubMed ID: 25664248
[TBL] [Abstract][Full Text] [Related]
18. Role of the ACE2/Ang-(1-7)/Mas axis in glucose metabolism.
Zhao S; Sun W; Jiang P
Rev Cardiovasc Med; 2021 Sep; 22(3):769-777. PubMed ID: 34565075
[TBL] [Abstract][Full Text] [Related]
19. Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis.
Grace JA; Klein S; Herath CB; Granzow M; Schierwagen R; Masing N; Walther T; Sauerbruch T; Burrell LM; Angus PW; Trebicka J
Gastroenterology; 2013 Oct; 145(4):874-884.e5. PubMed ID: 23796456
[TBL] [Abstract][Full Text] [Related]
20. The Anti-Inflammatory Potential of ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Evidence from Basic and Clinical Research.
Rodrigues Prestes TR; Rocha NP; Miranda AS; Teixeira AL; Simoes-E-Silva AC
Curr Drug Targets; 2017; 18(11):1301-1313. PubMed ID: 27469342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
